Story perspectives

Trump nominates Dr. Heidi Overton as FDA commissioner

8/20/2026

Left

Trump Nominates Overton

U.S. President Donald Trump announced on August 19, 2026 he will nominate Dr. Heidi Overton as FDA commissioner.
Critics note Overton’s anti-abortion stance and her support for splitting the MMR vaccine, raising concerns for reproductive health and vaccine confidence.
She was chief policy officer at the America First Policy Institute, a Trump-aligned think tank.
Her nomination follows FDA turmoil, turnover and Marty Makary’s resignation after rejecting flavored vape approvals.

Right

Trump Nominates Overton

U.S. President Donald Trump announced on August 19, 2026 that he will nominate Dr. Heidi Overton as commissioner of the Food and Drug Administration.
The announcement praised Overton’s long-time service, calling her a ‘rockstar’ health-policy leader.
Overton earned an MD from New Mexico and a Ph.D. from Johns Hopkins.
The agency lost a significant 3,000 staff and will inherit Overton’s food-pyramid and vaccine reforms.

Center

Trump Nominates Overton

U.S. President Donald Trump announced on August 19, 2026 that Dr. Heidi Overton will be nominated as commissioner of the Food and Drug Administration.
Overton briefed the president on an executive order that reduces the standard childhood vaccine schedule from 18 to 11 vaccines.
The White House lists Overton as deputy director of its Domestic Policy Council.
Her nomination follows Dr. Marty Makary’s May resignation, making her the administration’s third-choice candidate.

Blindspot

Overton has called the abortion medication mifepristone “dangerous” and urged limits on its mail-order availability in public statements.
Overton promoted an executive order to split the MMR vaccine into three separate shots, a step public-health experts described as dangerous.
Within this story's sources, this angle appears mainly in Left-leaning coverage and receives less attention in Center- and Right-leaning coverage.

History

Historical Context

David Kessler, appointed FDA commissioner in November 1990 and serving until February 1997, was reappointed by President Bill Clinton, cut drug-approval times, mandated Nutrition Facts labels, and pressed tobacco regulation that led to the Supreme Court’s 2000 Brown & Williamson decision limiting FDA authority. The 2024 nomination of Heidi Overton, who seeks to split the MMR vaccine and curb mifepristone, echoes those earlier regulatory confrontations.

1 of 5

Trump Nominates Overton

U.S. President Donald Trump announced on August 19, 2026 he will nominate Dr. Heidi Overton as FDA commissioner.
Critics note Overton’s anti-abortion stance and her support for splitting the MMR vaccine, raising concerns for reproductive health and vaccine confidence.
She was chief policy officer at the America First Policy Institute, a Trump-aligned think tank.
Her nomination follows FDA turmoil, turnover and Marty Makary’s resignation after rejecting flavored vape approvals.

1 / 5